Harmony TPV EMEA PMS

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2032

Conditions
Severe Pulmonary Valve Regurgitation
Interventions
RADIATION

Certain imaging assessments can be non-Standard of Care

Pre-Implant CT, Chest X-Ray at discharge and any related assessments during the following up visit, can be non-standard of care depending on site's / countries.

Trial Locations (12)

7

NOT_YET_RECRUITING

Mater Misericordiae University Hospital, Dublin

12203

NOT_YET_RECRUITING

Deutsches Herzzentrum der Charité, Berlin

22185

NOT_YET_RECRUITING

Skånes Universitetssjukhus Lund, Lund

28007

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

33600

NOT_YET_RECRUITING

CHU de Bordeaux - Hôpital Cardiologique du Haut-Leveque, Bordeaux

40138

NOT_YET_RECRUITING

Policlinico di Sant'Orsola, Bologna

49202

NOT_YET_RECRUITING

Schneider Children's Medical Center Israel, Petah Tikva

Unknown

RECRUITING

Rigshospitalet, Copenhagen

NOT_YET_RECRUITING

Herz - und Diabeteszentrum NRW, Bad Oeynhausen

NOT_YET_RECRUITING

Deutsches Herzzentrum München, Munich

NOT_YET_RECRUITING

Azienda Ospedaliera di Padova, Padua

04289

NOT_YET_RECRUITING

Helios Health Institute Standort Leipzig, Leipzig

Sponsors
All Listed Sponsors
lead

Medtronic Cardiovascular

INDUSTRY

NCT06906926 - Harmony TPV EMEA PMS | Biotech Hunter | Biotech Hunter